156 related articles for article (PubMed ID: 15746103)
1. Molecular dissection of the interaction between p27 and Kip1 ubiquitylation-promoting complex, the ubiquitin ligase that regulates proteolysis of p27 in G1 phase.
Kotoshiba S; Kamura T; Hara T; Ishida N; Nakayama KI
J Biol Chem; 2005 May; 280(18):17694-700. PubMed ID: 15746103
[TBL] [Abstract][Full Text] [Related]
2. Cytoplasmic ubiquitin ligase KPC regulates proteolysis of p27(Kip1) at G1 phase.
Kamura T; Hara T; Matsumoto M; Ishida N; Okumura F; Hatakeyama S; Yoshida M; Nakayama K; Nakayama KI
Nat Cell Biol; 2004 Dec; 6(12):1229-35. PubMed ID: 15531880
[TBL] [Abstract][Full Text] [Related]
3. Role of the UBL-UBA protein KPC2 in degradation of p27 at G1 phase of the cell cycle.
Hara T; Kamura T; Kotoshiba S; Takahashi H; Fujiwara K; Onoyama I; Shirakawa M; Mizushima N; Nakayama KI
Mol Cell Biol; 2005 Nov; 25(21):9292-303. PubMed ID: 16227581
[TBL] [Abstract][Full Text] [Related]
4. USP19 deubiquitinating enzyme supports cell proliferation by stabilizing KPC1, a ubiquitin ligase for p27Kip1.
Lu Y; Adegoke OA; Nepveu A; Nakayama KI; Bedard N; Cheng D; Peng J; Wing SS
Mol Cell Biol; 2009 Jan; 29(2):547-58. PubMed ID: 19015242
[TBL] [Abstract][Full Text] [Related]
5. Degradation of p27(Kip1) at the G(0)-G(1) transition mediated by a Skp2-independent ubiquitination pathway.
Hara T; Kamura T; Nakayama K; Oshikawa K; Hatakeyama S; Nakayama K
J Biol Chem; 2001 Dec; 276(52):48937-43. PubMed ID: 11682478
[TBL] [Abstract][Full Text] [Related]
6. PTEN regulates the ubiquitin-dependent degradation of the CDK inhibitor p27(KIP1) through the ubiquitin E3 ligase SCF(SKP2).
Mamillapalli R; Gavrilova N; Mihaylova VT; Tsvetkov LM; Wu H; Zhang H; Sun H
Curr Biol; 2001 Feb; 11(4):263-7. PubMed ID: 11250155
[TBL] [Abstract][Full Text] [Related]
7. KPC1 expression and essential role after acute spinal cord injury in adult rat.
Zhao J; Zhang S; Wu X; Huan W; Liu Z; Wei H; Shen A; Teng H
Neurochem Res; 2011 Mar; 36(3):549-58. PubMed ID: 21229311
[TBL] [Abstract][Full Text] [Related]
8. Triggering ubiquitination of a CDK inhibitor at origins of DNA replication.
Furstenthal L; Swanson C; Kaiser BK; Eldridge AG; Jackson PK
Nat Cell Biol; 2001 Aug; 3(8):715-22. PubMed ID: 11483956
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27.
Vlach J; Hennecke S; Amati B
EMBO J; 1997 Sep; 16(17):5334-44. PubMed ID: 9311993
[TBL] [Abstract][Full Text] [Related]
10. Involvement of two distinct ubiquitin E3 ligase systems for p27 degradation in corneal endothelial cells.
Lee JG; Kay EP
Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):189-96. PubMed ID: 18172092
[TBL] [Abstract][Full Text] [Related]
11. Molecular basis for the specificity of p27 toward cyclin-dependent kinases that regulate cell division.
Lacy ER; Wang Y; Post J; Nourse A; Webb W; Mapelli M; Musacchio A; Siuzdak G; Kriwacki RW
J Mol Biol; 2005 Jun; 349(4):764-73. PubMed ID: 15890360
[TBL] [Abstract][Full Text] [Related]
12. Structural basis of the Cks1-dependent recognition of p27(Kip1) by the SCF(Skp2) ubiquitin ligase.
Hao B; Zheng N; Schulman BA; Wu G; Miller JJ; Pagano M; Pavletich NP
Mol Cell; 2005 Oct; 20(1):9-19. PubMed ID: 16209941
[TBL] [Abstract][Full Text] [Related]
13. The F-box protein SKP2 mediates androgen control of p27 stability in LNCaP human prostate cancer cells.
Lu L; Schulz H; Wolf DA
BMC Cell Biol; 2002 Aug; 3():22. PubMed ID: 12188931
[TBL] [Abstract][Full Text] [Related]
14. Pirh2 promotes ubiquitin-dependent degradation of the cyclin-dependent kinase inhibitor p27Kip1.
Hattori T; Isobe T; Abe K; Kikuchi H; Kitagawa K; Oda T; Uchida C; Kitagawa M
Cancer Res; 2007 Nov; 67(22):10789-95. PubMed ID: 18006823
[TBL] [Abstract][Full Text] [Related]
15. Noncatalytic requirement for cyclin A-cdk2 in p27 turnover.
Zhu XH; Nguyen H; Halicka HD; Traganos F; Koff A
Mol Cell Biol; 2004 Jul; 24(13):6058-66. PubMed ID: 15199159
[TBL] [Abstract][Full Text] [Related]
16. p27(Kip1) stabilization and G(1) arrest by 1,25-dihydroxyvitamin D(3) in ovarian cancer cells mediated through down-regulation of cyclin E/cyclin-dependent kinase 2 and Skp1-Cullin-F-box protein/Skp2 ubiquitin ligase.
Li P; Li C; Zhao X; Zhang X; Nicosia SV; Bai W
J Biol Chem; 2004 Jun; 279(24):25260-7. PubMed ID: 15075339
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms underlying IGF-I-induced attenuation of the growth-inhibitory activity of trastuzumab (Herceptin) on SKBR3 breast cancer cells.
Lu Y; Zi X; Pollak M
Int J Cancer; 2004 Jan; 108(3):334-41. PubMed ID: 14648698
[TBL] [Abstract][Full Text] [Related]
18. Protein destruction: adapting roles for Cks proteins.
Harper JW
Curr Biol; 2001 Jun; 11(11):R431-5. PubMed ID: 11516665
[TBL] [Abstract][Full Text] [Related]
19. Kip1 degradation via the ubiquitin-proteasome pathway.
Tam SW; Theodoras AM; Pagano M
Leukemia; 1997 Apr; 11 Suppl 3():363-6. PubMed ID: 9209391
[TBL] [Abstract][Full Text] [Related]
20. The COP9 signalosome inhibits p27(kip1) degradation and impedes G1-S phase progression via deneddylation of SCF Cul1.
Yang X; Menon S; Lykke-Andersen K; Tsuge T; Di Xiao ; Wang X; Rodriguez-Suarez RJ; Zhang H; Wei N
Curr Biol; 2002 Apr; 12(8):667-72. PubMed ID: 11967155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
